Know Cancer

or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)
    VA Medical Center
    Oklahoma City, Oklahoma 73104
    Venous Thrombosis, Surgery, Deep Vein Thrombosis, Pulmonary Embolism, Venous Thromboembolism, Abdominal Surgery
    Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer, Peritoneal Cavity Cancer
    GW572016, An Oral Drug For Women With Refractory Metastatic Breast Cancer After First-line Or Second-line Herceptin
    GSK Investigational Site
    Oklahoma City, Oklahoma 73112
    Metastatic Breast Cancer
    Genetic Study of Young Patients With Colorectal Cancer
    Integris Oncology Services
    Oklahoma City, Oklahoma 73112
    Colorectal Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Breast Cancer
    S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lung Cancer
    Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
    Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Colorectal Cancer
    Clinical Trial for Ovarian Cancer (OvaRex®)
    Oklahoma University Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates - Mercy Campus
    Non-small Cell Lung Cancer
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Oklahoma University Medical Center

    Trial Locations
    Oklahoma University Medical Center
    Frank C. Love Cancer Institute at St. Anthony Hospital
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Malignant Mesothelioma
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Breast Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    The University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    OU Medical Center - Everett Tower
    Presbyterian
    OU Physicians' Bldg.
    Ovarian Neoplasms
    Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Penile Cancer
    Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
    INTEGRIS Southwest Medical Center

    Trial Locations
    INTEGRIS Southwest Medical Center
    Saint Anthony Hospital
    OU Medical Center
    Oklahoma City VA Medical Center
    Pulmonary Embolism
    Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
    Integris Baptist Medical Center
    Oklahoma City, Oklahoma 73112
    Hepatitis B
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Metastatic Cancer, Sarcoma
    Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Vulvar Cancer
    Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Lymphoma
    Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Endometrial Cancer
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    A Study of ABT-751 in Patients With Renal Cell Cancer
    US Oncology Inc Cancer Care Accociates-Mercy Campus
    Oklahoma City, Oklahoma 73120
    Renal Cell Cancer
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors
    Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Cancer Care Associates - Mercy Campus
    Oklahoma City, Oklahoma 73120
    Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Neutropenia
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Colorectal Cancer
    Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
    Local Institution
    Oklahoma City, Oklahoma
    Breast Cancer, Metastases
    Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma